Stroke Reviews suggest no benefit for treatment of acute ischemic stroke with<unk> , though they also emphasize the need for further high quality studies. In addition,<unk>  use was associated with a higher rate of spontaneous adverse events requiring hospitalization. Studies of ischemic stroke in Asian subpopulations also found an absence of benefit. An early study also suggested a lack of benefit with hemorrhagic stroke related to cerebral aneurysm. Dementia Reviews suggest an improvement in cognitive function with<unk>  use for vascular dementia, though as with studies on stroke, further high quality research is needed.
Cerebrolysin
Embelin
Amyloid beta
Retapamulin
Apamin
Tetraspanin
Glutamate-rich protein 3
Neurofilament light polypeptide